Clinical Trial Update: Weekly Paclitaxel and Trastuzumab in Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating weekly paclitaxel with trastuzumab in metastatic breast cancer has completed. The study was sponsored by WiSP Wissenschaftlich…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Taxol (paclitaxel)

Snippet

Sponsor: WiSP Wissenschaftlicher Service Pharma GmbH | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED